首页> 美国卫生研究院文献>Journal of Veterinary Internal Medicine >Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)

【2h】

Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)

机译：肌瘤二尖瓣病引起的犬脑血糖和螺旋酮组合的临床疗效：苯甲酸纤维素肺内酯研究（BESST）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The renin‐angiotensin‐aldosterone system (RAAS), when chronically activated, is harmful and RAAS‐suppressive drugs are beneficial in the treatment of congestive heart failure (CHF). Mineralocorticoid receptor antagonists are widely used in the treatment of CHF in people.

机译：在慢性激活时，肾素 - 血管紧张素 - 醛固酮系统（RAAS）是有害的，RAAS抑制药物有益于治疗充血性心力衰竭（CHF）。矿物质激素受体拮抗剂广泛用于人们治疗CHF。

著录项

期刊名称 Journal of Veterinary Internal Medicine
作者
Melissa Coffman; Emilie Guillot; Thomas Blondel; Catherine Garelli‐Paar; Shuo Feng; Susanne Heartsill; Clarke E. Atkins;
展开▼
作者单位

展开▼
年(卷),期 2021(35),4
年度 2021
页码 1673–1687
总页数 15
原文格式 PDF
正文语种
中图分类动物医学（兽医学）;
关键词

机译：ACE抑制剂;醛固酮突破;二尖瓣反流;MRA;raas;

相似文献

外文文献
专利

1. Effect of Pimobendan or Benazepril Hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. [J] . Haggstrom J., Boswood A., OGrady M., Kleintier-Praxis: Archiv fur Kleine Haus- und Nutztiere Sowie Laboratoriums- und Zoo-Tiere . 2008,第12期

机译：QUEST研究显示，匹莫苯或盐酸贝那普利对自然发生的粘液性二尖瓣疾病所致充血性心力衰竭犬的存活时间的影响。
2. Effect of Pimobendan or Benazepril Hydrochloride on Survival Times in Dogs with Congestive Heart Failure Caused by Naturally Occurring Myxomatous Mitral Valve Disease: The QUEST Study [J] . Journal of Veterinary Internal Medicine . 2008,第5期

机译：QUEST研究：吡莫苯丹或盐酸贝那普利对自然发生的粘液性二尖瓣疾病所致充血性心力衰竭犬存活时间的影响
3. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST Study. [J] . Haggstrom J., Boswood A., OGrady M., Journal of Veterinary Internal Medicine . 2013,第6期

机译：接受匹莫苯或贝那普利治疗的患有粘液性二尖瓣疾病的犬的生活质量，临床，影像学，超声心动图和实验室变量的纵向分析：QUEST研究。
4. PREDICTING FIRST ONSET OF CONGESTIVE HEART FAILURE IN DOGS WITH MITRAL VALVE DISEASE [C] . Mark A. Oyama American College of Veterinary Internal Medicine Forum . 2012

机译：二尖瓣病的狗犬充血性心力衰竭的首次发作
5. The impact of telemonitoring on self -efficacy, emotional well -being, and clinical outcomes in patients with chronic obstructive pulmonary disease or heart failure [D] . West-Frasier, Jaclyn 2008

机译：远程监护对慢性阻塞性肺疾病或心力衰竭患者自我效能，情绪健康和临床结局的影响
6. Evaluation of a fixed-dose combination of benazepril and pimobendan in dogs with congestive heart failure: a randomized non-inferiority clinical trial [O] . Jonathan N. King, Atsushi Hirakawa, Junko Sonobe, 2018

机译：评价苯那普利和匹莫苯的固定剂量联合治疗充血性心力衰竭的狗：一项非劣效性随机临床试验
7. Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy ( BESST ) [O] . Melissa Coffman, Emilie Guillot, Thomas Blondel, 2021

机译：肌瘤二尖瓣病引起的犬脑血糖和螺旋酮组合的临床疗效：苯甲酸纤维素肺内酯研究（BESST）

Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)

摘要

著录项

相似文献

相关主题

期刊订阅